GHRP-2

Overview

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic research peptide classified as a potent growth hormone secretagogue. It is studied in laboratory environments for its ability to stimulate the release of growth hormone by binding to the ghrelin receptor (GHS-R) in preclinical models such as laboratory rodents. GHRP-2 is often researched alongside other GHRH analogs to explore synergistic effects on growth hormone pathways.

Benefits

Preclinical studies suggest that GHRP-2 may help increase natural growth hormone secretion, support protein synthesis, and promote tissue repair and regeneration in test subjects. Research also indicates its potential to enhance appetite in laboratory animals, which can be useful for studies examining weight gain and energy balance.
Source: Bowers CY, et al. GHRP-2: a potent growth hormone-releasing hexapeptide. Journal of Clinical Endocrinology & Metabolism, 1996.

Possible Side Effects

In laboratory research, test subjects administered GHRP-2 may experience mild side effects such as temporary injection site irritation, slight water retention, increased appetite, or mild fluctuations in blood sugar markers. Effects depend on dosage, duration, and the species studied.
Source: Bowers CY, et al., JCEM, 1996.

Dosage & Administration

GHRP-2 is typically administered via subcutaneous injection according to approved laboratory protocols. Common research dosages range from 100 mcg to 300 mcg per injection, generally administered one to three times daily depending on the study design and research goals. It is often combined with a GHRH analog, such as Sermorelin, to optimize growth hormone release in preclinical models.
For laboratory research use only. Not for human consumption.

Summary

GHRP-2 is a synthetic growth hormone secretagogue peptide developed exclusively for laboratory research on natural growth hormone pathways, protein synthesis, and appetite stimulation in preclinical models. Research suggests it may help elevate growth hormone levels and support tissue repair, with mild side effects such as increased appetite or injection site irritation occasionally noted in test subjects. GHRP-2 is administered via subcutaneous injection, with dosage and frequency tailored to the specific study design and test species.
Strictly for research purposes only. Not for human use.